Journal
NATURE REVIEWS CANCER
Volume 4, Issue 9, Pages 718-727Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc1434
Keywords
-
Categories
Ask authors/readers for more resources
The cytoplasmic serine/threonine kinase BRAF and receptor tyrosine kinases of the platelet-derived growth factor receptor (PDGFR) family are frequently activated in cancer by mutations of an equivalent amino acid. Structural studies have provided important insights into why these very different kinases share similar oncogenic hot spots and why the PDGFR juxtamembrane region is also a frequent oncogenic target. This research has implications for other kinases that are mutated in human tumours and for the treatment of cancer using kinase inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available